Cell Apoptosis Detection by TUNEL Labeling: Signal Interpretation and Result Evaluation
Cell Apoptosis Detection by TUNEL Labeling: Signal Interpretation and Result Evaluation
The TUNEL assay is one of the most commonly used methods for detecting DNA fragmentation in apoptosis studies. Its detection target is the 3'-OH terminus of fragmented DNA rather than the apoptotic pathway itself. Therefore, interpretation of TUNEL results should not stop at the binary judgment of positivity or negativity, but should be based on nuclear localization, morphologic context, sample processing quality, and the integrity of the control system. In tissue sections, adherent cell preparations, and suspension cells alike, TUNEL can provide valuable information on DNA strand breakage. However, directly equating DNA fragmentation with apoptosis can readily lead to overinterpretation beyond the actual experimental intent.
Keywords: TUNEL labeling; apoptosis; DNA fragmentation; TdT; tissue sections; result interpretation
1. Detection Target and Methodological Boundaries of TUNEL Labeling
1.1 Reaction basis
The core of the TUNEL reaction is that terminal deoxynucleotidyl transferase (TdT) adds labeled nucleotides to 3'-OH termini at DNA strand breaks, thereby converting otherwise invisible DNA fragmentation into fluorescent or chromogenic signals. Because apoptotic cells are commonly accompanied by nuclear DNA fragmentation, TUNEL can be used to identify cell populations undergoing apoptosis-associated DNA breakage.
1.2 Sources of signal
TUNEL positivity is not restricted to classical apoptosis. In principle, any process that generates abundant DNA break termini may produce a positive signal, including:
(1) Endonuclease-mediated cleavage associated with apoptosis.
(2) Accumulation of strand breaks after severe DNA damage.
(3) Loss of nuclear integrity during necrosis or secondary necrosis.
(4) Artifactual DNA damage caused by improper tissue processing.
(5) Abnormal nuclear exposure due to excessive protease digestion, overly harsh permeabilization, or section damage.
1.3 Boundaries of result interpretation
TUNEL positivity may support the conclusion that “DNA fragmentation is increased in this region,” but it cannot by itself establish the following:
(1) The cell is definitively undergoing classical programmed apoptosis.
(2) Apoptosis is necessarily the predominant mode of cell death in the sample.
(3) The apoptotic pathway is necessarily caspase-dependent.
(4) A larger positive area necessarily indicates clearer biologic significance of apoptosis.
Results suitable for mechanistic interpretation should be integrated with cleaved caspase-3, PARP cleavage, BAX/BCL-2 changes, Annexin V, mitochondrial membrane potential, H&E morphology, or time-course data.
2. Differences Among Sample Types and Pre-analytical Handling
2.1 Paraffin sections
Paraffin sections are the most common sample type for TUNEL analysis. Their advantages include preserved tissue architecture, clear spatial localization, and suitability for analyzing apoptotic distribution within specific anatomic regions. Major confounding factors include fixation time, deparaffinization quality, protease treatment intensity, and necrotic background.
In paraffin samples, particular attention should be paid to the following:
(1) Overfixation leading to insufficient TdT penetration and inadequate end exposure.
(2) Incomplete deparaffinization causing uneven reagent permeation.
(3) Excessive protease digestion causing disruption of nuclear borders and increased false positivity.
(4) Extensive necrotic areas causing mixing of apoptotic and necrotic signals.
2.2 Frozen sections
In frozen sections, DNA is preserved more rapidly, and TUNEL signals may be more sensitive in some samples, but tissue integrity is usually poorer than in paraffin sections. If section storage, rewarming, or fixation is not properly controlled, nuclear structures are more easily damaged and background signals are more readily increased.
In frozen samples, the following points should be tightly controlled:
(1) Section thickness and structural integrity.
(2) Whether fixation time is appropriate.
(3) Whether the drying process causes nuclear damage.
(4) Whether freeze-thaw artifacts or edge-associated fragmentation are present.
2.3 Adherent cell preparations and suspension cells
In cell-based models, TUNEL is commonly used to assess apoptosis after drug treatment, oxidative stress, radiotherapy/chemotherapy injury, or genetic manipulation. Key variables in these samples include cell density, fixation method, permeabilization strength, and synchrony of cellular status.
Common biases in cell samples include:
(1) Excessive cell density causing overlap of nuclei.
(2) Overly strong permeabilization causing high background throughout the nucleus.
(3) Mechanical damage during centrifugation and washing of suspension cells.
(4) Sampling at time points that are too early or too late, resulting in mismatch between the DNA fragmentation window and the experimental objective.
Table 1. Key differences in TUNEL analysis among different sample types
Sample type | Advantages | Major risks | Key points for interpretation |
Paraffin sections | Preserved tissue architecture and clear localization | Strong dependence on fixation, deparaffinization, and digestion conditions | Spatial distribution of positive cells and correspondence with histologic structures |
Frozen sections | Faster DNA preservation and potentially higher sensitivity | Fragile structure and greater susceptibility to background elevation | Nuclear integrity, edge artifacts, and signal in clefts or tears |
Adherent cell preparations | High single-cell resolution | Permeabilization and fixation bias directly affect results | Single-nucleus signal pattern and positive-cell proportion |
Suspension cells | Suitable for batch detection or combination with flow cytometry | Strong interference from washing- and centrifugation-induced damage | Population-level positivity rate and interference from cell debris |
3. Key Control Points in the Experimental Workflow
3.1 Fixation and permeabilization
TUNEL results are strongly determined at the stages of fixation and permeabilization. Insufficient fixation compromises structural stability, whereas excessive fixation limits nuclear entry of TdT and exposure of fragmented DNA ends. Inadequate permeabilization leads to incomplete labeling, while excessive permeabilization increases nonspecific signal.
When generally weak positivity is observed despite preserved tissue architecture, insufficient permeability should be considered first. If diffuse nuclear staining across the entire section or cytoplasmic contamination is present, excessive permeabilization or overdigestion should be suspected.
3.2 Protease treatment
Protease K and related digestion steps are often used to improve reagent access, but they are also major sources of false-positive TUNEL signals. Insufficient digestion weakens the reaction, whereas excessive digestion causes disruption of nuclear borders, abnormal DNA exposure, and local tissue loosening, all of which may increase nonphysiologic positivity.
Protease treatment should be judged in conjunction with sample type:
(1) It may be moderately increased for long-fixed paraffin sections.
(2) It should be reduced for fragile tissue, necrotic tissue, and frozen sections.
(3) Adherent cell preparations usually do not require digestion intensity equivalent to that used for thick tissue sections.
(4) The same digestion time should not be mechanically applied across different tissue types.
3.3 Positive and negative controls
A complete control system is essential in TUNEL analysis.
Negative controls usually omit TdT or another key labeling step and are used to assess background of the detection system. If extensive nuclear positivity is still present in the negative control, background control has failed.
Positive controls are usually generated by DNase I pretreatment to produce detectable DNA break termini and are used to verify that the system is functioning properly. If the positive control shows no signal, experimental samples should not be directly interpreted as “non-apoptotic.”
3.4 Readout modalities
TUNEL can be performed either by fluorescence or by chromogenic methods such as DAB. Fluorescence-based readouts are more suitable for combined analysis with DAPI, Hoechst, or cell-type markers and facilitate single-cell localization. Chromogenic readouts are more suitable for paraffin sections and routine histopathologic observation.
Different readout modalities emphasize different interpretive priorities:
(1) Fluorescence-based readout focuses on intranuclear colocalization, single-cell resolution, and channel background.
(2) Chromogenic readout focuses on tissue architecture, morphology of positive cells, and regional distribution.
(3) Overexposure or overdevelopment can artificially enlarge the positive area.
(4) Image acquisition parameters must be kept consistent across groups.
4. Core Criteria for Interpreting TUNEL Results
4.1 Positive localization
The primary object of TUNEL interpretation is the nucleus. Signals with interpretive value usually appear as intranuclear focal or strong staining and colocalize with DAPI or Hoechst nuclear labeling. If signals are mainly located in the cytoplasm, extracellular debris, necrotic exudates, or section clefts, they should not be directly interpreted as apoptotic positivity.
When judging nuclear localization, the following should be emphasized:
(1) Whether the positive signal is strictly confined to the nuclear region.
(2) Whether positive nuclei show pyknosis, fragmentation, or peripheral chromatin condensation.
(3) Whether positive signals are concentrated in a defined cell population.
(4) Whether the positive region overlaps with obvious necrotic foci.
4.2 Positive intensity and positive rate
TUNEL results should not be judged solely by staining intensity. More important are the positivity rate and the distribution pattern of positive cells. A single strongly positive cell is not necessarily more informative than a broad region with moderate positivity. If signals are concentrated in a specific treatment group and show a stable distribution pattern, even moderate signal intensity may have substantial interpretive value.
Common quantitative indices include:
(1) Number of TUNEL-positive cells / total number of cells.
(2) TUNEL-positive area / target tissue area.
The former is more suitable for cell experiments and tissues with clearly defined cell boundaries, whereas the latter is more suitable for samples with extensive necrotic background, indistinct cell borders, or tissue-level comparisons.
4.3 Tissue distribution pattern
TUNEL interpretation cannot be separated from histologic context. Apoptosis commonly appears as scattered or focal nuclear positivity. In contrast, broad diffuse positivity across an entire necrotic region more often suggests necrosis or severe DNA destruction rather than a simple increase in apoptosis. In tumors, ischemic injury, neural tissues, and inflammatory tissues, spatial distribution is often more informative than total positivity alone.
Table 2. Interpretive framework for TUNEL-positive signals
Interpretive dimension | Features supporting an apoptotic interpretation | Features requiring caution |
Localization | Clear intranuclear signal colocalizing with nuclear stain | Diffuse signal in cytoplasm, extracellular space, clefts, or necrotic regions |
Morphology | Nuclear pyknosis, nuclear fragmentation, focal positivity | Structural collapse and broad intense positivity without clear boundaries |
Distribution | Scattered, clustered, or region-specific increase associated with treatment | Random increase across the entire section or concentration at edge artifacts |
Controls | Low background in the negative control and normal response in the positive control | Elevated signal in the negative control itself or failure of the positive control |
Consistency | Concordant with H&E morphology and apoptotic markers | Overlap with necrosis, mechanical injury, or processing artifacts |
5. Common Sources of Misinterpretation and Experimental Pitfalls
5.1 Directly equating DNA fragmentation with apoptosis
This is the most common interpretive error in TUNEL analysis. TUNEL detects DNA break termini rather than the apoptotic pathway itself. DNA damage, necrosis, tissue injury, and processing artifacts may all produce positive signals.
5.2 Misinterpretation of necrotic regions
Necrotic areas often contain abundant fragmented DNA and nuclear debris and therefore commonly exhibit extensive high-intensity signals. Without reference to H&E staining or tissue morphology, these signals are easily misinterpreted as markedly increased apoptosis.
5.3 Misinterpretation of edge artifacts
Section edges, folded regions, knife marks, and detached boundaries are more prone to artifactual high background. If these signals appear in all groups and are concentrated at the edges, they should generally be excluded from quantification.
5.4 Over-quantification
TUNEL is often oversimplified as “more positivity means stronger apoptosis.” This statement is not rigorous. Depending on tissue type, time point, and injury model, elevated TUNEL signals may reflect enhanced early apoptosis, late secondary necrosis, or progression of tissue damage, and their biologic meaning is not uniform.
6. Integrated Interpretation of TUNEL with Other Indicators
6.1 Integration with morphology
H&E staining, DAPI/Hoechst nuclear labeling, and ultrastructural observation provide an essential basis for interpreting TUNEL results. If TUNEL positivity is consistent with nuclear pyknosis, fragmentation, and apoptotic body formation, interpretation becomes more robust.
6.2 Integration with apoptotic pathway markers
When combined with cleaved caspase-3, cleaved PARP, BAX/BCL-2, cytochrome c release, and related indicators, TUNEL more readily supports an evidence chain linking DNA fragmentation to activation of apoptotic pathways. If TUNEL positivity is increased while caspase-dependent markers remain unchanged, noncanonical cell death pathways or processing artifacts should be considered.
6.3 Integration with time-course analysis
In apoptosis studies, time points are often more important than a single endpoint. If sampling is too early, TUNEL signals may not yet be obvious; if sampling is too late, apoptotic cells may already have been cleared or may have progressed to secondary necrosis. Establishing a time-course framework makes it easier to relate TUNEL results to injury, repair, or treatment effects.
Table 3. Common combinations for integrated interpretation of TUNEL
Combined marker | Main purpose | Interpretive value |
H&E morphology | Distinguish apoptotic from necrotic background | Provides histologic context |
DAPI/Hoechst | Define nuclear localization and nuclear morphology | Improves single-cell interpretive accuracy |
Cleaved caspase-3 | Verify activation of apoptotic pathways | Strengthens mechanistic interpretation |
Annexin V | Complement early apoptotic information | Compensates for the temporal limitation of TUNEL |
Ki-67/proliferation markers | Analyze the balance between proliferation and apoptosis | Improves interpretation of tissue dynamics |
7. Interpretive Priorities in Different Experimental Scenarios
7.1 Cell experiments
In cell-based models, interpretation of TUNEL should focus on single-cell nuclear signals, positivity rate, and treatment-time dependence. Result descriptions should preferably use expressions such as “the proportion of TUNEL-positive cells increased” or “intranuclear fragmentation signals were enhanced.”
7.2 Tissue injury models
In ischemia-reperfusion, inflammatory injury, neurodegenerative models, and drug-toxicity models, TUNEL signals often coexist with necrosis and inflammatory cell infiltration. In these samples, interpretation should emphasize the regional localization of positive cells, cell type identity, and the spatial relationship to necrotic areas.
7.3 Tumor studies
In tumor samples, TUNEL may reflect therapy-induced apoptosis, but may also be associated with central tumor necrosis, treatment-related DNA damage, or hypoxic microenvironments. In tumor research, TUNEL interpretation should be integrated with recognition of necrotic areas, stratification of tumor edge versus central regions, and proliferation markers.
8. Recommended Wording for Experimental Results
8.1 Appropriate expressions for the Results section
Result descriptions should focus on localization, proportion, distribution, and intergroup differences. For example:
(1) The proportion of TUNEL-positive cells increased in the treatment group, with signals primarily localized within nuclei.
(2) Positive cells were concentrated at the injury margin rather than within the central necrotic core.
(3) Combined DAPI staining showed that positive cells were accompanied by nuclear pyknosis and fragmentation.
(4) The negative control showed low background, and the positive control responded adequately, indicating a stable detection system.
8.2 Expressions that should not be directly used in the Results section
The following statements involve excessive extrapolation and should generally be avoided:
(1) TUNEL positivity proves that the cells are definitely undergoing classical apoptosis.
(2) Increased TUNEL signal proves that a specific pathway has been activated.
(3) Expansion of the positive area alone demonstrates a stronger treatment effect.
(4) A reduction in weak positivity alone proves that a protective effect has been established.
9. TUNEL-Related Products
9.1 Basic reagent table for TUNEL detection
Name | CAS No. | Experimental step | Key use | Notes for use |
Proteinase K | Sample pretreatment | Improves exposure of DNA termini within tissues or nuclei and enhances accessibility of the TdT reaction | Excessive treatment may disrupt nuclear borders and increase false positivity | |
DNase I | Positive control preparation | Artificially generates DNA break termini to verify that the TUNEL system is functioning properly | Used only for positive controls and not for interpretation of experimental groups | |
Hydrogen peroxide | Blocking before chromogenic development | Blocks endogenous peroxidase activity in DAB-based systems and reduces tissue background | Mainly used for HRP-DAB TUNEL readout | |
3,3'-Diaminobenzidine (DAB) | Chromogenic detection | Produces a brown chromogenic signal in HRP-based systems for tissue localization under bright-field microscopy | Excessive development can enlarge the apparent positive area | |
Triton X-100 | Permeabilization | Improves entry of TdT and labeled nucleotides into nuclei | Overpermeabilization may cause high nuclear background or nuclear structural damage | |
Sodium citrate | Buffer preparation | Can be used for selected pretreatment steps or for establishing a buffer environment for nuclease-related reactions | Used as a supporting buffer component in the method | |
Formaldehyde | Fixation | Used for fixation of cells or tissues to preserve nuclear architecture and sample morphology | Both insufficient and excessive fixation can affect TUNEL results | |
Hoechst 33342 | Nuclear counterstaining | Used for nuclear localization and colocalization analysis in fluorescent TUNEL assays | Suitable for observing pyknosis and nuclear fragmentation | |
Propidium iodide (PI) | Nuclear counterstaining / auxiliary damage interpretation | Used in some fluorescence systems for nuclear staining and auxiliary evaluation of cell death status | Requires distinction from the strong staining background of necrotic cells | |
Glycerol | Mounting | Used in some fluorescence mounting systems to maintain imaging stability | For long-term storage, combination with antifade systems is preferred |
9.2 Supporting product table for TUNEL detection
Product category | Catalog No. | Name | Grade and purity | Suitable research use/application |
Core enzyme | Terminal deoxyribonucleotidyltransferase | — | Core enzyme for the TUNEL reaction, used to add labeled dUTP to DNA break termini | |
Core enzyme | Terminal Deoxynucleotidyl Transferase | EnzymoPure™, biologically active, ActiBioPure™, sterile, DNase- and RNase-free, 5.0 U/μL | Suitable for routine TUNEL end-labeling reactions | |
Core enzyme | Terminal Deoxynucleotidyl Transferase (TdT) | ActiBioPure™, biologically active, EnzymoPure™, sterile, DNase- and RNase-free, 20 U/μL | Suitable for batch processing or high-activity TdT systems | |
Core enzyme | Terminal Deoxynucleotidyl Transferase (TdT, 20U/μL) | ActiBioPure™, biologically active, EnzymoPure™, DNase- and RNase-free, 20 U/μL | Suitable for high-activity end-labeling reactions in tissue sections or cell samples | |
Labeled substrate | Biotin dUTP (biotin dUTP) | — | Suitable for biotin-based TUNEL systems with subsequent streptavidin- or HRP-mediated amplification | |
Labeled substrate | Biotin TUNEL apoptosis Kit | — | Suitable for biotin-based TUNEL detection in tissue-section chromogenic workflows or amplified detection | |
Labeled substrate | Biotin-11-dUTP trisodium | ≥99% | Suitable for constructing biotin-based TdT end-labeling systems | |
Labeled substrate | Biotin-16-dUTP trisodium | ≥97% | Suitable for constructing biotin-labeled TUNEL systems with longer linker length | |
Labeled substrate | Sulfo-Cy3-E-dUTP | — | Suitable for orange-red fluorescent TUNEL detection | |
Labeled substrate | Sulfo-cy3-e-dutp (sulfo-cy3-ethyl-dutp) | — | Suitable for Cy3-channel fluorescent TUNEL labeling | |
Labeled substrate | Sulfo-Cy5 dUTP | — | Suitable for far-red TUNEL labeling | |
Labeled substrate | Sulfo-Cy5.5 dUTP | — | Suitable for longer-wavelength fluorescent TUNEL detection | |
Labeled substrate | Tetramethylrhodamine-dUTP | — | Suitable for rhodamine-channel TUNEL labeling | |
Labeled substrate | Vari Fluor 488-dUTP | ≥99% | Suitable for green fluorescent TUNEL labeling | |
Labeled substrate | Vari Fluor 555-dUTP | — | Suitable for orange-red fluorescent TUNEL detection | |
Labeled substrate | Vari Fluor 594-dUTP | — | Suitable for red fluorescent TUNEL labeling | |
Labeled substrate | Vari Fluor 640-dUTP | ≥98% | Suitable for far-red fluorescent TUNEL labeling | |
Kit | Colorimetric TUNEL Apoptosis Assay Kit | BioReagent, colorimetric method, for microscopy | Suitable for paraffin tissue sections or routine bright-field TUNEL interpretation | |
Kit | Aladdin ® 488 TUNEL apoptosis Kit (green fluorescence) | — | Suitable for green fluorescent TUNEL detection | |
Kit | Aladdin ® 555 TUNEL apoptosis Kit (orange red fluorescence) | — | Suitable for orange-red channel TUNEL detection | |
Kit | Aladdin ® 594 TUNEL apoptosis Kit (red fluorescence) | — | Suitable for red-channel TUNEL detection | |
Kit | Aladdin ® 640 TUNEL apoptosis Kit (far red fluorescence) | — | Suitable for far-red channel TUNEL detection | |
Mounting and imaging | Enhanced Antifade Mounting Medium | BioReagent, suitable for fluorescence analysis and immunofluorescence (IF) | Suitable for post-imaging mounting in fluorescent TUNEL assays to reduce quenching | |
Mounting and imaging | Fluorescent Mounting Media | — | Suitable for endpoint mounting of fluorescent TUNEL samples | |
Mounting and imaging | Antifluorescent quencher | — | Suitable for long-term preservation and observation of fluorescent TUNEL sections | |
Mounting and imaging | Antifade Mounting Medium | — | Suitable for mounting fluorescent TUNEL samples | |
Mounting and imaging | AntiFade Mounting Medium (with DAPI) | BioReagent, suitable for immunofluorescence (IF) and immunohistochemistry (for IHC) | Suitable for direct mounting and nuclear counterstaining after fluorescent TUNEL labeling | |
Mounting and imaging | AntiFade Mounting Medium (with Hoechst 33342 and PI) | BioReagent, suitable for immunohistochemistry (for IHC) and immunofluorescence (IF) | Suitable for combined observation of fluorescent TUNEL, nuclear morphology, and PI signal | |
Mounting and imaging | AntiFade Mounting Medium (with Hoechst 33342) | BioReagent, suitable for immunohistochemistry (for IHC) and immunofluorescence (IF) | Suitable for combined interpretation of fluorescent TUNEL and Hoechst nuclear localization | |
Mounting and imaging | AntiFade Mounting Medium (with PI) | BioReagent, suitable for immunofluorescence (IF) and immunohistochemistry (for IHC) | Suitable for combined observation of TUNEL and PI signals related to nuclear damage and late-stage cell death | |
Mounting and imaging | Polyvinyl Alcohol Anti-Fluorescence Quenching Mounting Medium | Suitable for immunofluorescence (IF), BioReagent, for microscopy, suitable for fluorescence analysis | Suitable for long-term storage of fluorescent TUNEL samples and reduction of fluorescence quenching | |
Mounting and imaging | Fischor Mounting Medium | BioReagent, for microscopy, suitable for immunofluorescence (IF), suitable for immunohistochemistry (for IHC) | Suitable for endpoint mounting in chromogenic TUNEL or selected fluorescent TUNEL workflows | |
Mounting and imaging | mounting medium | Unscented | Suitable for basic mounting after routine TUNEL imaging | |
Mounting and imaging | Routine Glycerol Mounting Medium | BioReagent, for microscopy, suitable for immunofluorescence (IF), suitable for fluorescence analysis | Suitable for basic mounting of fluorescent TUNEL samples | |
Mounting and imaging | Glycerol PBS Mounting Medium | BioReagent, for microscopy, suitable for immunofluorescence (IF), suitable for fluorescence analysis | Suitable for routine mounting of fluorescent TUNEL samples | |
Mounting and imaging | Polyvinyl Alcohol Glycerol Mounting Medium | BioReagent, for microscopy, suitable for immunofluorescence (IF), suitable for immunohistochemistry (for IHC) | Suitable for mounting and short- to medium-term preservation of TUNEL sections | |
Mounting and imaging | Gum Arabic Glycerol Mounting Medium | BioReagent, for microscopy, suitable for microbiology, immunofluorescence (IF), and immunohistochemistry (for IHC) | Suitable for mounting TUNEL samples for routine microscopic observation |
The experimental value of the TUNEL assay lies in its ability to convert the apoptosis-associated event of DNA fragmentation into a stable and observable signal. Its interpretive difficulty arises from the fact that DNA fragmentation is not exclusive to apoptosis. A reliable TUNEL result does not depend on whether the signal is the strongest, but on whether nuclear localization is clear, morphology is concordant, controls are valid, and combined indicators support the interpretation.